The FDA announced that it will take enforcement action against companies who manfucture unapproved prescription drug products that contain hydrocodone.
Hydrocodone, one of the strongest pain relief and cough suppressants, can result in breathing problems or cardiac arrest when used improperly. Manufacturing and distribution of unapproved hydrocodone products to children under the age of 6 must end by October 31, 2007. Marketing of other unapproved hydrocodone products must cease being produced by December 31, 2007 and must cease to be shipped by March 31, 2008.
The FDA warns that legal action could be taken against those who do not comply by failing to meet the deadlines.
Comment Preview